Board Meeting13 Oct 2026, 04:05 pm
GlaxoSmithKline Pharmaceuticals Board Meeting on Nov 3, 2026
AI Summary
GlaxoSmithKline Pharmaceuticals Ltd has announced that its Board of Directors will convene on November 3, 2026. The primary agenda item for this meeting is to consider, approve, and take on record the Unaudited Financial Results for the second quarter and half-year ended September 30, 2026. This announcement is made in compliance with LODR Regulations.
Key Highlights
- Board meeting scheduled for November 3, 2026.
- To approve Unaudited Financial Results for Q2 and H1 FY27.
- Results pertain to the period ending September 30, 2026.
- Compliance with LODR Regulations is noted.
Price Impact
More from GLAXO